ScholarIQanswers from OpenAlex
European Institute of Oncology
InstitutionResearch output, impact & collaborations
European Institute of Oncology is a institution indexed in ScholarIQ from OpenAlex.
What is known about European Institute of Oncology?
ScholarIQrecord summary
European Institute of Oncology is a research organisation in Milan, IT. OpenAlex records 22,589 works and 3,426,513 citations for it. 3,310 researchers list it as their most recent affiliation.
How many works does European Institute of Oncology have?
ScholarIQindexed works
European Institute of Oncology has 22,589 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does European Institute of Oncology have?
ScholarIQcitation count
European Institute of Oncology has 3,426,513 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at European Institute of Oncology?
ScholarIQresearcher count
European Institute of Oncology has 3,310 researchers in the ScholarIQ index.
What is the average h-index at European Institute of Oncology?
ScholarIQavg h-index
European Institute of Oncology has an average h-index of 82.4 in OpenAlex.
What is the ROR of European Institute of Oncology?
ScholarIQror
The ROR for European Institute of Oncology is on the source record.
What is the OpenAlex record for European Institute of Oncology?
ScholarIQopenalex
The OpenAlex for European Institute of Oncology is on the source record.
What is the Wikidata of European Institute of Oncology?
ScholarIQwikidata
The Wikidata for European Institute of Oncology is on the source record.
Who are the most-cited researchers behind European Institute of Oncology?
ScholarIQtop researchers by citations
What are the most-cited papers on European Institute of Oncology?
ScholarIQmost cited works
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
Kathleen N. Moore, Nicoletta Colombo, Giovanni Scambia, Byoung‐Gie Kim, Ana Oaknin, Michael Friedländer, Alla Lisyanskaya, Anne Floquet, Alexandra Léary, Gabe S. Sonke, Charlie Gourley, Susana Banerjee, Amit M. Oza, Antonio González-Martı́n, Carol Aghajanian, William H. Bradley, Cara Mathews, Joyce F. Liu, Elizabeth Lowe, Ralph Bloomfield, Paul DiSilvestro
Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer
Isabelle Ray‐Coquard, Patricia Pautier, Sandro Pignata, David Pérol, Antonio González-Martı́n, Regina Berger, Keiichi Fujiwara, Ignace Vergote, Nicoletta Colombo, Johanna Mäenpää, Frédèric Selle, Jalid Sehouli, Domenica Lorusso, Eva María Guerra Alia, Alexander Reinthaller, Shoji Nagao, Claudia Lefeuvre‐Plesse, Ulrich Canzler, Giovanni Scambia, Alain Lortholary, Frederik Marmé, Pierre Combe, Nikolaus de Gregorio, Manuel Rodrigues, Paul Buderath, Coraline Dubot, Alexander Burges, Benoît You, Éric Pujade-Lauraine, Philipp Harter
ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma
Nicole Concin, Xavier Matías‐Guiu, Ignace Vergote, David Cibula, Mansoor Raza Mirza, Simone Marnitz, Jonathan A. Ledermann, Tjalling Bosse, Cyrus Chargari, Anna Fagotti, Christina Fotopoulou, Antonio González-Martı́n, Sigurd Lax, Domenica Lorusso, Christian Marth, Philippe Morice, Remi A. Nout, D. O’Donnell, Denis Querleu, Maria Rosaria Raspollini, Jalid Sehouli, Alina Sturdza, Alexandra Taylor, Anneke M. Westermann, Pauline Wimberger, Nicoletta Colombo, François Planchamp, Carien L. Creutzberg
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up
Nicoletta Colombo, Carien L. Creutzberg, Frédéric Amant, Tjalling Bosse, Antonio González-Martı́n, Jonathan A. Ledermann, Christian Marth, Remi A. Nout, Denis Querleu, Mansoor Raza Mirza, Cristiana Sessa, Miguel Abal, Özden Altundağ, Frédéric Amant, Antoni Van Leeuwenhoek, Susana Banerjee, Tjalling Bosse, Antonio Casado, L Chiva de Agustín, David Cibula, Nicoletta Colombo, Carien L. Creutzberg, José María Del Campo, Günter Emons, Frédéric Goffin, Antonio González-Martı́n, Stefano Greggi, Christine Haie-Méder, Dionyssios Katsaros, Vesna Kesić, Christian Kurzeder, Sigurd Lax, Fabrice Lécuru, Jonathan A. Ledermann, Tally Levy, Domenica Lorusso, Johanna Mäenpää, Christian Marth, Xavier Matías‐Guiu, Philippe Morice, Hans W. Nijman, Remi A. Nout, Melanie Powell, Denis Querleu, Mansoor Raza Mirza, Nicholas Reed, Alexandros Rodolakis, Helga B. Salvesen, Jalid Sehouli, Cristiana Sessa, Alexandra Taylor, Anneke M. Westermann, Alain G. Zeimet
Alcohol consumption and site-specific cancer risk: a comprehensive dose–response meta-analysis
Vincenzo Bagnardi, Matteo Rota, Edoardo Botteri, Irene Tramacere, Farhad Islami, Veronika Fedirko, Lorenza Scotti, Mazda Jenab, Federica Turati, Elena Pasquali, Claudio Pelucchi, Carlotta Galeone, Rino Bellocco, Eva Negri, Giovanni Corrao, Paolo Boffetta, Carlo La Vecchia
Who collaborates most closely around European Institute of Oncology?
ScholarIQco-authorship network
United States
50%
Germany
50%
MOST FREQUENT PARTNER INSTITUTIONS
How much of the research on European Institute of Oncology is open access?
ScholarIQopen access share
75%OPEN ACCESS